Atlas Trials

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

Clinical trial NCT05004285 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05004285
Sponsor
FutureChem
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
High Risk Prostate Carcinoma
Start date
2021-04-28
Primary completion
2025-06-01
Enrollment
398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.